Revenue

Global consulting giant Andersen partners with niche firm Scimitar to tackle pharma's biggest challenges, signaling a new model for expertise at scale.

Snowflake's move to buy AI observability firm Observe challenges market incumbents by merging big data analytics with AI-powered troubleshooting.

With key studies now complete, Biofrontera's light-based therapy Ameluz could soon offer a new weapon against widespread actinic keratosis and stubborn acne.

A new partnership introduces Utilix, an intelligent software aiming to transform static displays into dynamic, data-driven experiences for retail and beyond.

Zoom launches a new grant program celebrating solo entrepreneurs using AI, signaling a strategic bet on the rapidly growing 'business of one' economy.

With a new EV plant in Santa Teresa, GreenPower aims for market dominance while New Mexico pushes its ambitious clean energy and economic development goals.

With the strategic hire of development veteran Mitch Friedel, Hilco Global is leveraging its new capital strength to dominate the booming experiential retail market.

The investment giant's new podcast season tackles the energy trilemma, exploring AI's power thirst, the return of nuclear, and fossil fuel's role.

A new partnership arms independent cancer clinics with advanced AI and data analytics, aiming to improve patient care and ensure their survival.

A new class of painkillers promises the power of opioids with a far lower risk of addiction. Tris Pharma's cebranopadol could reshape pain management.

BEGA's new BEGA Connect platform leverages cloud power and NB-IoT to simplify architectural lighting control, eliminating servers and subscription fees.

A breakthrough liquid biopsy shows over 80% accuracy in finding feline lymphoma, offering a non-invasive screening tool for vets and hope for cat owners.

Industry veteran Wes Champion takes the helm at VMG Health, signaling a new era of aggressive, PE-backed expansion in the complex healthcare consulting market.

After surviving three brain aneurysms, Francelys Infante launches N2B4B, a beauty brand built on resilience, self-worth, and the art of Kintsugi.

ITRS's acquisition of French DEM leader IP-Label signals a major move to challenge market giants by creating a holistic observability platform for Europe.

NeuroSense adds world-renowned expert Prof. Steven Arnold to its board, a major vote of confidence in its multi-target Alzheimer's drug, PrimeC.

A new study on oral testosterone therapy for men 65-80 could reshape geriatric care, challenge FDA guidelines, and unlock a multi-billion dollar market.

The new venue near EpicCentral isn't just another opening; it's a strategic move in a competitive market, fueling local growth and redefining leisure.

As fraud losses top $43B, Vonage’s network-powered Identity Insights API wins a key award for redefining security and trust in the digital economy.

While humanoid robots grab headlines, Linkerbot quietly captured 80% of the dexterous hand market with revolutionary cost and production scale.